Thiamine Supplementation in Heart Failure Patients Receiving Full Medical Therapy

• Status: Completed
• Trial end date: 2010-12-01
• Target enrollment: 0
• Participant gender: All

Summary

The study is performed to consider the effect of thiamine supplementation on symptoms and signs of patients with heart failure and systolic and diastolic function of left ventricle.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Mashhad University of Medical Sciences
• Treatments: Thiamine

Criteria

Inclusion Criteria:

• Heart failure patients (left ventricular ejection fraction (LVEF ≤ 40%)

• Optimal medical therapy according to the present guidelines for at least 3 months before enrollment.

Exclusion Criteria:

• Decompensated heart failure

• Renal failure

• COPD

• Asthma

• Uncontrolled hypertension

• Bradycardia or tachycardia which needs increase or decrease in medications